CKPT Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 2.10%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $2,234,109.38

Checkpoint Therapeutics Insider Trading History Chart

Checkpoint Therapeutics Share Price & Price History

^$3.99

▲ +0.01 (0.25%)

As of 03/13/2025 05:00 PM ET

Days: 30 | 90 | 365

Checkpoint Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/10/2025	James F Oliviero III	CEO	Sell	10,331	$3.15	$32,542.65	3,775,019
2/7/2025	James F Oliviero III	CEO	Sell	9,233	$3.41	$31,484.53	3,785,350
2/6/2025	William Garrett Gray	CFO	Sell	74,110	$3.67	$271,983.70	1,458,644
12/19/2024	James F Oliviero III	CEO	Sell	220,230	$3.38	$744,377.40	3,194,583
12/18/2024	William Garrett Gray	CFO	Sell	268,432	$4.01	$1,076,412.32	1,032,754
6/26/2024	James F Oliviero III	CEO	Sell	24,610	$2.05	$50,450.50	1,977,170
6/26/2024	William Garrett Gray	CFO	Sell	13,038	$2.06	$26,858.28	672,186
2/28/2024	James F Oliviero III	CEO	Sell	5,894	$2.06	$12,141.64	350,836
2/28/2024	William Garrett Gray	CFO	Sell	2,035	$2.07	$4,212.45	145,224
2/1/2024	James F Oliviero III	CEO	Sell	11,900	$2.01	$23,919.00	369,680
2/1/2024	William Garrett Gray	CFO	Sell	4,115	$1.95	$8,024.25	147,259
3/2/2023	James F Oliviero III	CEO	Sell	5,483	$5.00	$27,415.00	144,090
3/2/2023	William Garrett Gray	CFO	Sell	3,591	$5.00	$17,955.00	51,374
2/27/2023	James F Oliviero III	CEO	Sell	5,548	$4.65	$25,798.20	134,573
2/27/2023	William Garrett Gray	CFO	Sell	1,914	$4.66	$8,919.24	47,465
2/1/2023	James F Oliviero III	CEO	Sell	10,261	$4.77	$48,944.97	182,121
2/1/2023	William Garrett Gray	CFO	Sell	3,154	$4.79	$15,107.66	49,379
1/10/2023	James F Oliviero III	CEO	Sell	3,817	$6.75	$25,764.75	192,382
1/10/2023	William Garrett Gray	CFO	Sell	1,858	$6.75	$12,541.50	52,533
6/23/2022	James F Oliviero III	CEO	Sell	1,500	$11.10	$16,650.00	256,200
6/21/2022	James F Oliviero III	CEO	Sell	2,100	$10.90	$22,890.00	258,900
6/17/2022	James F Oliviero III	CEO	Sell	22,800	$10.90	$248,520.00	261,000
4/13/2022	James F Oliviero III	CEO	Sell	2,125	$15.10	$32,087.50	283,800
4/4/2022	James F Oliviero III	CEO	Sell	8,635	$17.90	$154,566.50	287,329

See Full Table

SEC Filings (Institutional Ownership Changes) for Checkpoint Therapeutics (NASDAQ:CKPT)

22.00% of Checkpoint Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Checkpoint Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/24/2025	Ameriflex Group Inc.	9,900	$32K	0.0%	N/A	0.020%
2/21/2025	PVG Asset Management Corp	123,475	$0.40M	1.9%	-17.6%	0.253%
2/17/2025	Squarepoint Ops LLC	71,938	$0.23M	0.0%	N/A	0.147%
2/17/2025	Two Sigma Investments LP	73,032	$0.23M	0.0%	+73.8%	0.150%
2/17/2025	Man Group plc	10,919	$35K	0.0%	N/A	0.022%
2/17/2025	OMERS ADMINISTRATION Corp	116,900	$0.37M	0.0%	N/A	0.239%
2/17/2025	Millennium Management LLC	54,186	$0.17M	0.0%	N/A	0.111%
2/17/2025	D. E. Shaw & Co. Inc.	29,695	$95K	0.0%	-66.4%	0.061%
2/17/2025	Cetera Investment Advisers	20,237	$65K	0.0%	-23.3%	0.041%
2/17/2025	Balyasny Asset Management L.P.	20,221	$65K	0.0%	N/A	0.041%
2/17/2025	Bank of America Corp DE	90,041	$0.29M	0.0%	+30,216.8%	0.184%
2/17/2025	683 Capital Management LLC	163,109	$0.52M	0.0%	N/A	0.334%
2/14/2025	Schonfeld Strategic Advisors LLC	46,897	$0.15M	0.0%	N/A	0.096%
2/14/2025	Northern Trust Corp	72,563	$0.23M	0.0%	+16.4%	0.149%
2/14/2025	Boothbay Fund Management LLC	10,888	$35K	0.0%	N/A	0.022%
2/14/2025	Stifel Financial Corp	10,149	$32K	0.0%	N/A	0.021%
2/14/2025	Tower Research Capital LLC TRC	10,616	$34K	0.0%	+157.0%	0.022%
2/13/2025	Marshall Wace LLP	11,172	$36K	0.0%	-82.2%	0.023%
2/13/2025	Walleye Capital LLC	44,500	$0.14M	0.0%	-32.5%	0.091%
2/13/2025	Raymond James Financial Inc.	20,995	$67K	0.0%	N/A	0.043%
2/13/2025	Envestnet Asset Management Inc.	66,835	$0.21M	0.0%	-20.1%	0.137%
2/12/2025	Geode Capital Management LLC	445,111	$1.43M	0.0%	+4.1%	0.912%
2/11/2025	Virtu Financial LLC	38,157	$0.12M	0.0%	+180.5%	0.078%
2/6/2025	Raymond James Financial Inc.	20,995	$67K	0.0%	N/A	0.043%
2/6/2025	Atria Investments Inc	37,295	$0.12M	0.0%	-22.2%	0.076%
2/6/2025	Charles Schwab Investment Management Inc.	20,000	$64K	0.0%	N/A	0.041%
2/6/2025	SBI Securities Co. Ltd.	10,081	$32K	0.0%	N/A	0.021%
1/30/2025	PUREfi Wealth LLC	10,000	$32K	0.0%	N/A	0.020%
1/29/2025	Gladstone Institutional Advisory LLC	61,399	$0.20M	0.0%	+75.4%	0.126%
1/17/2025	Bartlett & CO. Wealth Management LLC	19,000	$61K	0.0%	+375.0%	0.039%
1/15/2025	HB Wealth Management LLC	153,560	$0.51M	0.0%	+96.9%	0.314%
11/25/2024	PVG Asset Management Corp	149,870	$0.34M	1.3%	+9.2%	0.307%
11/20/2024	Virtu Financial LLC	13,605	$30K	0.0%	N/A	0.028%
11/16/2024	Geode Capital Management LLC	427,651	$0.96M	0.0%	+41.2%	0.950%
11/15/2024	State Street Corp	94,424	$0.21M	0.0%	+32.2%	0.210%
11/14/2024	Walleye Capital LLC	65,948	$0.15M	0.0%	N/A	0.146%
10/28/2024	Gladstone Institutional Advisory LLC	35,000	$78K	0.0%	+141.4%	0.098%
10/24/2024	Wealth Enhancement Advisory Services LLC	130,000	$0.29M	0.0%	+160.0%	0.364%
10/15/2024	Magnus Financial Group LLC	35,000	$78K	0.0%	+12.9%	0.098%
8/22/2024	PVG Asset Management Corp	137,194	$0.30M	1.2%	N/A	0.384%
8/19/2024	B. Riley Wealth Advisors Inc.	229,200	$0.49M	0.0%	+366.3%	0.642%
8/15/2024	Armistice Capital LLC	2,506,000	$5.39M	0.1%	-7.7%	7.022%
8/12/2024	XTX Topco Ltd	15,605	$34K	0.0%	N/A	0.044%
8/9/2024	Renaissance Technologies LLC	77,200	$0.17M	0.0%	-71.5%	0.216%
8/7/2024	Choreo LLC	65,002	$0.13M	0.0%	+12.2%	0.182%
7/17/2024	180 Wealth Advisors LLC	42,750	$96K	0.0%	N/A	0.120%
5/16/2024	B. Riley Wealth Advisors Inc.	49,150	$0.10M	0.0%	-69.9%	0.138%
5/10/2024	Vanguard Group Inc.	917,894	$1.88M	0.0%	+67.4%	2.572%
5/2/2024	Choreo LLC	57,922	$0.12M	0.0%	+200.9%	0.162%
4/25/2024	Lindbrook Capital LLC	30,000	$62K	0.0%	N/A	0.084%
3/15/2024	B. Riley Wealth Advisors Inc.	163,350	$0.37M	0.0%	+232.3%	0.694%
2/13/2024	Tower Research Capital LLC TRC	11,174	$26K	0.0%	+92.7%	0.047%
2/13/2024	Armistice Capital LLC	2,426,000	$5.56M	0.1%	+17.5%	10.310%
2/5/2024	Choreo LLC	19,250	$44K	0.0%	N/A	0.082%
2/5/2024	Magnus Financial Group LLC	24,000	$55K	0.0%	N/A	0.102%
12/1/2023	B. Riley Wealth Advisors Inc.	49,150	$84K	0.0%	+9.4%	0.209%
11/15/2023	Sabby Management LLC	205,247	$0.35M	0.3%	N/A	0.951%
11/15/2023	Armistice Capital LLC	2,064,000	$3.51M	0.1%	+46.1%	9.560%
11/1/2023	Legacy Wealth Asset Management LLC	85,000	$0.14M	0.1%	+104.8%	0.394%
10/27/2023	PVG Asset Management Corp	111,025	$0.19M	1.3%	+81.9%	0.514%
10/26/2023	Park Avenue Securities LLC	59,932	$0.10M	0.0%	N/A	0.278%
8/11/2023	D.A. Davidson & CO.	10,000	$25K	0.0%	N/A	0.077%
8/10/2023	Meitav Investment House Ltd.	28,970	$3.68M	0.1%	N/A	0.224%
8/10/2023	Cetera Investment Advisers	15,290	$38K	0.0%	N/A	0.118%
8/4/2023	Legacy Wealth Asset Management LLC	41,500	$0.10M	0.0%	N/A	0.320%
8/4/2023	Apollon Wealth Management LLC	44,429	$0.11M	0.0%	+29.2%	0.343%
7/31/2023	PVG Asset Management Corp	61,025	$0.15M	0.7%	-55.5%	0.471%
7/27/2023	B. Riley Wealth Advisors Inc.	44,945	$0.11M	0.0%	+26.1%	0.347%
7/24/2023	Meitav Investment House Ltd.	28,970	$3.68M	0.1%	N/A	0.224%
5/9/2023	Cowen AND Company LLC	220,000	$0.50M	0.1%	N/A	1.699%
5/8/2023	Emfo LLC	15,715	$35K	0.0%	+101.6%	0.121%
3/15/2023	B. Riley Wealth Advisors Inc.	19,150	$98K	0.0%	-87.8%	0.206%
2/7/2023	Envestnet Asset Management Inc.	27,805	$0.14M	0.0%	-71.0%	0.299%
2/2/2023	Emfo LLC	7,795	$40K	0.0%	-95.9%	0.084%
1/31/2023	Ironwood Investment Management LLC	12,564	$64K	0.0%	-91.0%	0.135%
1/24/2023	Park Avenue Securities LLC	46,545	$0.24M	0.0%	-57.8%	0.500%
1/4/2023	Bartlett & Co. LLC	5,000	$26K	0.0%	-90.0%	0.054%
11/18/2022	Spotlight Asset Group Inc.	661,597	$0.62M	0.6%	N/A	7.114%
11/14/2022	Baader Bank Aktiengesellschaft	88,200	$9.88M	0.8%	N/A	0.095%
11/8/2022	Apollon Wealth Management LLC	129,351	$0.14M	0.0%	+31.9%	0.140%
11/8/2022	Atom Investors LP	68,734	$71K	0.0%	N/A	0.074%
10/21/2022	Morgan Jess S & Co. Inc.	1,894,694	$1.97M	1.7%	+66.6%	2.048%
10/13/2022	PVG Asset Management Corp	392,375	$0.41M	1.6%	N/A	0.424%
8/11/2022	Apollon Wealth Management LLC	98,095	$0.10M	0.0%	+29.5%	0.108%
7/27/2022	Park Avenue Securities LLC	110,176	$0.11M	0.0%	-47.6%	0.121%
7/18/2022	Morgan Jess S & Co. Inc.	1,137,322	$1.17M	1.2%	+3.9%	1.249%
5/16/2022	Morgan Jess S & Co. Inc.	1,094,714	$1.94M	1.4%	-6.9%	1.208%
5/12/2022	Healthcare of Ontario Pension Plan Trust Fund	1,107,100	$1.96M	0.0%	N/A	1.222%
4/29/2022	Park Avenue Securities LLC	210,176	$0.37M	0.0%	+289.2%	0.232%
3/8/2022	Bartlett & Co. LLC	50,000	$0.16M	0.0%	N/A	0.060%
2/15/2022	Mirabella Financial Services LLP	21,700	$67K	0.0%	N/A	0.026%
2/11/2022	Level Four Advisory Services LLC	10,000	$31K	0.0%	N/A	0.012%
2/10/2022	Qube Research & Technologies Ltd	43,444	$0.14M	0.0%	N/A	0.052%
2/10/2022	Paradigm Financial Partners LLC	42,000	$0.12M	0.0%	N/A	0.050%
2/10/2022	Ironwood Investment Management LLC	136,155	$0.42M	0.2%	+3.2%	0.163%
2/9/2022	Alps Advisors Inc.	96,944	$0.30M	0.0%	N/A	0.116%
2/4/2022	Envestnet Asset Management Inc.	66,847	$0.21M	0.0%	+12.0%	0.080%
2/3/2022	Advisor Group Holdings Inc.	98,503	$0.31M	0.0%	+51.4%	0.118%
2/2/2022	PVG Asset Management Corp	80,307	$0.25M	0.9%	-9.9%	0.096%
2/1/2022	Qube Research & Technologies Ltd	43,444	$0.14M	0.0%	N/A	0.052%

Data available starting January 2016

See Full Table

Checkpoint Therapeutics, Inc., a clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers in the United States and internationally. The company's lead antibody product candidate is Cosibelimab, which is in Phase 1 clinical trial to treat patients with selected recurrent or metastatic cancers; and CK-302, a product candidate in preclinical trials for hematological malignancies and solid tumors. It is developing Olafertinib, which is in Phase 3 clinical trials for the treatment of adult patients with metastatic non-small cell lung cancer; CK-103 for the treatment of various advanced and metastatic solid tumor cancers; and Anti-Carbonic Anhydrase IX (CAIX) antibody, a product candidate in preclinical trials to recognize CAIX expressing cells and kill them via antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity. The company has licensing and collaboration agreements with Adimab, LLC for the development of Cosibelimab; NeuPharma, Inc., to develop and commercialize Olafertinib; and Jubilant Biosys Limited for the development and commercialization of novel compounds that inhibit BET bromodomains. The company was incorporated in 2014 and is based in Waltham, Massachusetts. Checkpoint Therapeutics, Inc. is a subsidiary of Fortress Biotech, Inc.

Today's Range

Now: $3.99

$3.98

$4.00

50 Day Range

MA: $3.15

$2.38

$4.00

52 Week Range

Now: $3.99

$1.38

$4.50

Volume

5,648,925 shs

Average Volume

2,499,784 shs

Market Capitalization

$194.84 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.41

Who are the company insiders with the largest holdings of Checkpoint Therapeutics?: Checkpoint Therapeutics' top insider investors include:
James F Oliviero III (CEO)
William Garrett Gray (CFO)
Learn More about top insider investors at Checkpoint Therapeutics.
Who are the major institutional investors of Checkpoint Therapeutics?: Checkpoint Therapeutics' top institutional investors include:
Geode Capital Management LLC — 0.91%
Citadel Advisors LLC — 0.00%
683 Capital Management LLC — 0.33%
HB Wealth Management LLC — 0.31%
PVG Asset Management Corp — 0.25%
OMERS ADMINISTRATION Corp — 0.24%
Learn More about top institutional investors of Checkpoint Therapeutics stock.
Which institutional investors are selling Checkpoint Therapeutics stock?: Within the last quarter, CKPT stock was sold by these institutional investors:
D. E. Shaw & Co. Inc.
Marshall Wace LLP
PVG Asset Management Corp
Walleye Capital LLC
Envestnet Asset Management Inc.
Atria Investments Inc
Cetera Investment Advisers
Within the previous year, company insiders that have sold Checkpoint Therapeutics company stock include:
James F Oliviero III (CEO)
William Garrett Gray (CFO)
Learn More investors selling Checkpoint Therapeutics stock.
Which institutional investors are buying Checkpoint Therapeutics stock?: In the previous quarter, CKPT stock was purchased by institutional investors including:
Citadel Advisors LLC
683 Capital Management LLC
OMERS ADMINISTRATION Corp
Bank of America Corp DE
HB Wealth Management LLC
Squarepoint Ops LLC
Group One Trading LLC
Millennium Management LLC